Progyny Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	62.04	30.36	65.77	46.46	-8.57	-5.54	-13.47
Depreciation & Amortization	2.28	1.6	1.3	1.91	2.13	1.88	1.56
Share-Based Compensation	122.61	100.75	33.71	12.82	5.06	3	1.56
Other Operating Activities	1.89	-52.31	-74.74	-24.98	-0.16	2.93	-0.14
Operating Cash Flow	188.81	80.4	26.04	36.2	-1.53	2.27	-9.47
Operating Cash Flow Growth	134.86%	208.77%	-28.08%	-	-	-	-
Capital Expenditures	-3.64	-3.24	-2.13	-1.04	-2.96	-0.58	-0.61
Change in Investments	-196.88	-40.63	10.9	-38.99	0	0	0
Other Investing Activities	-	-	-	-	0.2	2.48	-
Investing Cash Flow	-200.53	-43.87	8.77	-40.03	-2.76	1.9	-0.61
Share Issuance / Repurchase	6.13	4.23	4.27	2.68	84.8	-1.14	0.03
Debt Issued / Paid	0	0	0	0	-0.25	-5.1	-3.26
Other Financing Activities	-17.2	-12.09	-17.97	-8.93	-	-2.5	15
Financing Cash Flow	-11.07	-7.86	-13.7	-6.25	84.55	-8.74	11.77
Exchange Rate Effect	0	0	0	0	0	0	0
Net Cash Flow	-22.78	28.67	21.11	-10.08	80.26	-4.56	1.68
Free Cash Flow	185.17	77.15	23.91	35.17	-4.49	1.69	-10.09
Free Cash Flow Growth	140.00%	222.71%	-32.01%	-	-	-	-
Free Cash Flow Margin	17.01%	9.80%	4.78%	10.20%	-1.95%	1.61%	-20.76%
Free Cash Flow Per Share	1.95	0.84	0.27	0.41	-0.22	0.31	-1.78

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).